Nomura Research Group

Research

Our Team

Publications

Our new discovery⁩ by ⁦@MLuo18⁩ ⁦@j_sprads⁩ ⁦@NovartisScience⁩ #maimonelab of fully synthetic covalent E3 ligase R… twitter.com/i/web/status/1…

Stephan Hacker @StephanHacker2

Interesting paper by the group of Craig Hutton @Hutton_Lab with first author Mohammad Haskali in @rsc_medchem. They sho…

Stephan Hacker @StephanHacker2

Interesting paper from the group of Dustin Maly @UW with first author Zack Potter in @CellChemBiol. They use a method t…

Dan Nomura @DanNomura

Thankful to all the happy birthday wishes for my 39th birthday! Even with the coronavirus pandemic this past year,… twitter.com/i/web/status/1…

Dan Nomura @DanNomura

Covalent inhibitors: a rational approach to drug discovery - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D… twitter.com/i/web/status/1…

Craig Crews @CraigMCrews

So proud of my team for our @ACSCentSci paper on the first small molecule #KRas #PROTAC! And a special shoutout to Cesar…

Nello Mainolfi @NelloMainolfi

Excited to partner with @sanofi to power up our IRAK4 program in immune-inflammatory diseases. Fulfilling our mission to…

Stephan Hacker @StephanHacker2

New paper by the groups of A. Itzen and C. Hedberg in @NatureChemistry. They use cysteine-selective chemistry to covale…

Optimal linker length for small molecule PROTACs that selectively targ... sciencedirect.com/science/articl…

Chemo- Proteomics

Chemical Biology

Drug Discovery

Nomura

Covalent Ligand Discovery

Natural Product Target Discovery

Induced Proximity Modalities

Nomura

Reimagining Druggability using Chemoproteomic Platforms